(Q40715235)

23 September 2017

title

Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cells (English)

1 reference

23 September 2017

1 reference

Amy E Lovett-Racke

1 reference

23 September 2017

Michael K Racke

series ordinal

1 reference

23 September 2017

publication date

1 January 2002

1 reference

23 September 2017

1 reference

inferred from page(s)

published in

Cellular Immunology

1 reference

23 September 2017

volume

215

1 reference

23 September 2017

1 reference

23 September 2017

page(s)

54-60

1 reference

T cells responsive to myelin basic protein in patients with multiple sclerosis

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Suppression of experimental allergic encephalomyelitis by retinoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Longitudinal study of myelin basic protein-specific T-cell receptors during the course of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Bronchospasm induced by isotretinoin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Exacerbation of asthma by isotretinoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Tolerability of the synthetic retinoid Fenretinide (HPR)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Long-term tolerability of fenretinide (4-HPR) in breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 α, 25-(OH)2D3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Vitamin A and Retinoids in Health and Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Modulation of interferon (IFN)-inducible gene expression by retinoic acid. Up-regulation of STAT1 protein in IFN-unresponsive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900013-8

10.1016/S0008-8749(02)00013-8

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference